Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives

Respiratorytract infections (RTIs) are frequent and life-threatening diseases, accounting for several millions of deaths worldwide. RTIs implicate microorganisms, including viruses (influenza virus, coronavirus, respiratory syncytial virus (RSV)), bacteria (Pseudomonas aeruginosa, Streptococcus pneu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayor, Alexie, Chesnay, Adélaïde, Desoubeaux, Guillaume, Ternant, David, Heuzé-Vourc’h, Nathalie, Sécher, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917879/
https://www.ncbi.nlm.nih.gov/pubmed/33668613
http://dx.doi.org/10.3390/vaccines9020151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917879/
https://www.ncbi.nlm.nih.gov/pubmed/33668613
http://dx.doi.org/10.3390/vaccines9020151

Ejemplares similares